Content about GlaxoSmithKline

LONDON — GlaxoSmithKline announced the results from the first of eight phase-3 clinical trials that examined the efficacy of albiglutide in the treatment of Type 2 diabetes.

The Harmony 7 trial was a 32-week, head-to-head, open-label, noninferiority study that compared albiglutide, an investigational once weekly glucagon-like peptide-1 agonist, with once-daily liraglutide. According to the results, patients administered GSK's drug saw a 0.78% reduction in HbA1C, while patients administered liraglutide saw a 0.99% reduction in HbA1C.

NEW YORK — CVS/pharmacy. Rite Aid. Walgreens. Sam’s Club. Ahold. H-E-B. The Katz Group. Giant Eagle. Good Neighbor. Health Mart. The list of participating companies in the 13th Annual Drug Store News Group Industry Issues conference — which will be held Tuesday, Nov. 29, here at the highly prestigious New York Athletic Club — reads like a “who’s who” of pharmacy retailing.

PITTSBURGH — Generic drug maker Mylan has bought rights to a drug delivery platform made by Pfizer that will allow it to make generic versions of two GlaxoSmithKline respiratory drugs, Mylan said Wednesday.

BERKELEY, Calif. — An experimental vaccine for hepatitis B made by Dynavax Technologies appears to work better in patients with diabetes than current treatments, the company said.

Sales in the digestives aisle going forward look positive, especially as an aging population begins paying closer attention to healthy diets, including the right amount of dietary fiber to keep things “regular” and supplementation with probiotics for overall digestive health.


PHILADELPHIA — The Food and Drug Administration has declined to approve a vaccine developed by GlaxoSmithKline, the drug maker said.

LONDON — GlaxoSmithKline is making a donation that it said would give more than 10,000 girls and women access to human papillomavirus vaccination.

GSK announced that it would donate $1 million worth of Cervarix (human papillomavirus bivalent [types 16 and 18] vaccine, recombinant) to the Pink Ribbon Red Ribbon Partnership over the next five years, as well as $50,000 to support the program operations. The partnership is an initiative led by Susan G. Komen for the Cure, UNAIDS, the President's Emergency Relief Plan for AIDS Relief and the George W. Bush Institute.

PITTSBURGH — GlaxoSmithKline's Consumer Healthcare division has appointed a former Kraft Foods executive as its new chief customer officer.

In his new role, Keith Loranger will be responsible for leading the GSK Consumer Healthcare’s sales function to increase sales and profit for the company’s oral health and wellness categories, including such brands as Aquafresh, NicoDerm CQ and Tums, among others. Prior to joining the company, Loranger served as Kraft Foods' customer VP international strategy after joining the company in 1985.


As the clock winds down on the patent exclusivity of the industry’s biggest blockbuster drug in November, speculation continues to grow that Pfizer will look to flip the switch on an OTC version of Lipitor (atorvastatin) before generic competition whittles away at the $7 billion behemoth. 


The expansive oral care market continues to swell as manufacturers further develop toothpastes that promise to provide specific results.

According to SymphonyIRI Group, toothpaste sales for the 52 weeks ended Aug. 7 at food, drug and mass (excluding Walmart) rose nearly 5% to $1.35 billion. Those toothpastes that experienced the greatest growth were those that touted such benefits as whitening and easing tooth sensitivity.

HAYWARD, Calif. — Patients taking an experimental treatment for Parkinson's disease experienced greater reduction in symptoms than those taking a drug already on the market, according to results of a late-stage clinical trial.

PITTSBURGH — GlaxoSmithKline Consumer Healthcare on Monday named John Graham chief marketing officer for Consumer Healthcare, North America.